Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products
New Drug Application (NDA) for avasopasem is currently under priority review by the U.S. Food and Drug Administration (FDA) with a…
Source: www.marketscreener.com – Read more
Galera Expands Commercial Leadership Team
Must Read
OneMain pays $4.5M after ignored security flaws caused data breaches
OneMain Financial experienced at least three lengthy cybersecurity events between 2018 and 2020 brought on by a host of security program and access control...
